Plain-English translation of NCT06785272 on ClinicalTrials.gov โ ยท Source last updated ยท Translation generated ยท How we translate trials
Phase 3 โ Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing , a mineral that may help relieve severe asthma attacks in children. Researchers want to see whether giving this medication through an IV (a thin tube in the vein) after initial emergency asthma treatment helps children breathe better and recover more quickly. Half the children will receive the medication and half will receive salt water (a placebo) to compare results.
Some children have asthma attacks that don't improve enough with standard emergency treatments like inhalers and steroids. Doctors believe this medication might help those children breathe easier, but they need to run this study to prove it actually works and is safe.
You likely qualify ifโฆ
You likely don't qualify ifโฆ
If you join this study, you'll come to the emergency department where you'll first receive standard asthma treatment (inhalers and steroids). Then a research nurse will give you either the magnesium medication or salt water through an IV over 30 minutes. You'll be monitored closely for 3 hours in the emergency department, with the nurse checking your breathing, heart rate, blood pressure, and oxygen levels. You may also receive other asthma medicines recommended by your doctor during this time. Finally, the research team will follow up with you by phone or email 72 hours after you leave the hospital.
AI-generated summary from trial data ยท Jun 5, 2026 ยท Not medical advice
Canada